-

Verséa Health, Inc. Announces the Official Launch of Empowered Choice™ – An Affordable and Accessible Emergency Contraceptive

TAMPA, Fla.--(BUSINESS WIRE)--Verséa Health, Inc. (“Verséa”), a Florida-based transformative healthcare company specializing in the commercialization of innovative diagnostics, therapeutics, and health services, has officially launched Empowered Choice™, a safe and effective over-the-counter emergency contraceptive.

Empowered Choice™ is an FDA approved, 1.5 mg Levonorgestrel tablet that provides the same proven effective emergency contraception as the market leading product Plan B One Step® at a more affordable price point and available in more accessible outlets.

"In response to the growing demand for affordable and accessible emergency contraceptive options, we recognized the need to provide a reliable solution through more accessible outlets, enabling individuals to obtain the care they need without barriers or delays," said James M. Olin, Chief Commercial Officer of Verséa Health, Inc.

“At Verséa Health, we believe choice is fundamental to individual autonomy and reproductive health. The name 'Empowered Choice™' embodies our commitment to fostering a sense of agency in every person’s journey. We chose this name to emphasize that everyone has the right to make informed decisions regarding their health, particularly in critical moments.”

Empowered Choice™ is now available for purchase at select convenience stores, adult sexual health and wellness, and specialty retailers nationwide, as well as online at Amazon.com.

For inquiries regarding distributorship opportunities for Empowered Choice™, please contact Verséa Health, Inc. at diagnostics@versea.com or call 1-800-397-0670. To learn more about Empowered Choice™, please visit the product webpage.

About Verséa Health, Inc.

Verséa Health, Inc. (“Verséa”) headquartered in Tampa, FL, is a U.S. based transformative health care company on a mission to deliver their “3P’s Model”: Proactive Health, Preventative Health, and Precision Medicine. Verséa Health operates across three strategic business units: Diagnostics (Professional & Consumer), Ophthalmics, and Discovery. To learn more, visit: www.versea.com

Disclaimer: Empowered Choice™ is a trademark of Verséa Health, Inc. Plan B One‑Step® is a registered trademark of Foundation Consumer Healthcare (FCH).

Contacts

Verséa Health, Inc.
James M. Olin, CCO
1-800-397-0670
jolin@versea.com

Industry:

Verséa Health, Inc.

Release Versions
English
Hashtags
#EmergencyContraceptive
#EmpoweredChoice
#VerseaHealth
#WomensHealth
#business
#diagnostics
#healthcare
#industrynews
#therapeutics
#versea

Contacts

Verséa Health, Inc.
James M. Olin, CCO
1-800-397-0670
jolin@versea.com

Social Media Profiles
Verséa Health, Inc.
Verséa Health, Inc.
Verséa Health, Inc.
Verséa Health, Inc.
More News From Verséa Health, Inc.

Eye Health America and Verséa Ophthalmics, Inc. Enter Into a Preferred Partnership to Support Management of Ocular Surface Disease and Ocular Surgery

GREENVILLE, S.C. & TAMPA, Fla.--(BUSINESS WIRE)--Eye Health America and Verséa Ophthalmics, Inc. Enter Into a Preferred Partnership to Support Management of Ocular Surface Disease and Ocular Surgery....

Verséa Discovery, Inc. Announces the Official Launch of mescreen™ Research Validator – a Revolutionary Mitochondrial Compound Assessment Platform

TAMPA, Fla.--(BUSINESS WIRE)--Verséa Discovery, Inc., a Florida-based company dedicated to advancing scientific research and development in the area of personalized and precision medicine, has announced the official launch of mescreen™ Research Validator. The mescreen™ Research Validator is a groundbreaking, proprietary compound assessment platform that harnesses mitochondrial function and dynamics to generate critical data, supporting the development, formulation, and clinical validation of cu...

Verséa Health, Inc. Announces the Official Launch of Party Safe™ Fentanyl ID Test – A Convenient and Accurate Solution for Fentanyl Detection On-the-Go

TAMPA, Fla.--(BUSINESS WIRE)--Verséa Health, Inc. (“Verséa”), a Florida-based transformative healthcare company specializing in the commercialization of innovative diagnostics, therapeutics, and health services, has officially launched Party Safe™ Fentanyl ID Test. Manufactured by a leading US supplier to law enforcement and healthcare providers, Party Safe™ Fentanyl ID Test is a dependable over-the-counter product, featuring 5 test strips, an easy-to-use format, and a straightforward instructi...
Back to Newsroom